Physician profile
Mark Bergmann
NPI 1669431805
$3,461.24
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,651 · 2020: $289 · 2021: $297 · 2022: $224.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $2,000.00 | 2019 | |
| Sun Pharmaceutical Industries INC. | $437.98 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $233.47 | 2019-2021 | |
| Shire North American Group INC | $152.19 | 2019 | |
| Oyster Point Pharma, INC. | $122.07 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $118.60 | 2021 | |
| Alcon Vision LLC | $87.44 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $82.00 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $65.54 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $51.17 | 2019-2021 | |
| Allergan, INC. | $33.46 | 2021 | |
| Biotissue Holdings INC. | $29.16 | 2022 | |
| Glaukos Corporation | $20.22 | 2022 | |
| Eyevance Pharmaceuticals LLC | $15.77 | 2022 | |
| Horizon Therapeutics Plc | $12.17 | 2021 |
2 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bergmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.